Accueil Ernstrade Bourse Actualite Stock
 
plus500
Exchanges: Germany

MagForce AG is a leader in the area of nanotechnology-based cancer treatment, and the first company worldwide to receive European approval for a medical product using nanoparticles. The novel therapy is available to patients at the NanoTherm®therapy center in Germany at the Charité-Universitätsmedizin Berlin. Additional therapy centers throughout Germany are planned for 2012.

http://www.magforce.de/

 

Copyright  2012  Ernstrade.com